Tobira Therapeutics' Series B - II Round

Tobira Therapeutics raised a round of funding on September 13, 2010.

Tobira is a clinical-stage biopharmaceutical company focused on the development and commercialization of therapies to treat liver disease, inflammation, fibrosis and HIV. The company's lead product, c…

Articles about Tobira Therapeutics' Series B - II Round: